Stories of Success

See One of Our Clients Share His Story About Working with Commenda in the Video Below:

Provided seed venture capital in the amount of $3,000,000 and served as a member of the Board of Directors.

Represented microtek in a M&A buy-side engagement prior to the sale of the company.

Represented the Board of this leading business process services and background screening company as it evaluated reviewed the potential sale of the company.

Represented this SaaS based CRM technology company and Aurora Funds in the sale of the company.

Served as a financial advisor on a $5,500,000 Series A Round of Venture Capital of this leading pharmaceutical marketing services company.

Served as a financial advisor, a seed capital investor in the $7,000,000 Series A round and as a board member for this leading Assisted Living Facilities (ALF) company.

Served as an officer of Healtheon|WebMD after it merged with WebMD in a transaction valued at $3,500,000,000.

Served as an officer of Healtheon|WebMD when it merged with Medical Manager Health Systems in a transaction valued at $5,600,000,000

Served as an officer of WebMD which acquired Greenberg News

Served as an officer of WebMD which acquired onhealth in a transaction valued at $150,000,000

Served as an officer of WebMD, which acquired ENVOY for $2,500,000,000

Served as financial advisor and board member during corporate restructuring of this leading management and technology consulting company.

Served as financial advisor and board member on early stage recapitalization of this compliance monitoring and management company.

Served as financial advisor and sole investment banker on the sale of Merryvale Assisted Living to CaraVita Senior Living Centers. $3,000,000

Served as financial advisor on the company’s Initial Public Offering (IPO) and on one secondary offering of common stock in the amount of $25,000,000

Served as financial advisor on the company’s initial public offering (IPO) and on two secondary public offerings of its common stock. $200,000,000

Served as financial advisor to this leading pathology services company, backed by Summit Partners, in its $80,000,000 IPO.

Served as financial analyst and advisor on sale of the company to HEALTHSOUTH for $1,500,000,000

Served as financial analyst and investment advisor on common stock offering $60,000,000

Served as financial analyst and investment advisor on the company’s PIK preferred stock placement.

Served as the sole financial advisor to the Board in the development of its business plan targeting the home health market and identified strategic partners for this patient monitoring and automated medication dispensing company.

Served as a financial advisor, seed investor, and board member when company raised a Series A venture round $500,000

Commenda team member served as a founder, seed investor and Board member of Quality Surgery Centers, a surgery center management company.

Commenda team member served as the exclusive financial advisor to SURGICOE in the sale of the company to United Surgical Partners International for $37,000,000 in its first multi-center acquisition.

Commenda team member was a seed venture capital investor in the amount of $3,000,000

Commenda team member was a seed venture capital investor in the amount of $3,000,000

Commenda team member served as an officer of the company when it merged with Healtheon – $4,000,000,000

Served as venture investor and board member in U.S. Orthopedics, which merged into NSH.

Provided advisory services and helped tap capital markets to facilitate company growth.

Acted as financial advisor on M&A transaction and facilitated related equity raise.

Provided advisory services for credit facility access, management execution and marketing strategy.

Founded, developed, managed and sold this $2.0 BN institutional investment management business. In addition to SMAs, created, funded and managed two private Caymen domiciled investment funds.

Advised on the development and implementation of the investment management program for this $300 MM directed donation. Objective was to maximize return while ensuring adequate liquidity for five specific capital investments.

Structured and placed over $2.0 BN in synthetic fixed and variable rate debt. Included the development of an internet based Financial Risk Management System to monitor all derivative positions and support all hedge accounting requirements.

Advised on the management of a $10.0 MM operating investment portfolio. The objective was maximize returns while maintaining liquidity for operations.

Advised on the structuring and placement of over $100 MM in variable and synthetic fixed rate debt for these two high end continuum of care retirement centers. In addition, directed the investment of all bond proceeds.

Clients